Michigan-Based Niowave Preps $20 Million Expansion in Lansing

Niowave, a medical isotope manufacturer, plans to invest $20 million in expanding its Lansing, Michigan facility, which is expected to create more jobs. The company’s technology is used for medical diagnostics and cancer treatment. Niowave President Mike Zamiara cited the unique combination of science and advanced manufacturing talent as the reason for choosing Lansing nearly 20 years ago and is excited to expand the company’s operations in the area.

According to Governor Gretchen Whitmer, Niowave chose Lansing due to the availability of skilled workers in the region. As part of the expansion, Niowave plans to add 35 high-paying technical jobs to the area. This investment is supported by a $500,000 performance-based grant from the Michigan Economic Development Corporation.

By investing in this expansion, Niowave hopes to tap into the skilled talent pool of the Lansing region and increase its capacity to manufacture medical isotopes. This expansion will contribute to the development of the local economy and create job opportunities for the community.